Neuroradiological evaluation of demyelinating disease

Jan Mendelt Tillema, Istvan Pirko

Research output: Contribution to journalArticlepeer-review

37 Scopus citations


Central nervous system inflammatory demyelinating disease can affect patients across the life span. Consensus definitions and criteria of all of the different acquired demyelinating diseases that fall on this spectrum have magnetic resonance imaging criteria. The advances of both neuroimaging techniques and important discoveries in immunology have produced an improved understanding of these conditions and classification. Neuroimaging plays a central role in the accurate diagnosis, prognosis, disease monitoring and research efforts that are being undertaken in this disease. This review focuses on the imaging spectrum of acquired demyelinating disease.

Original languageEnglish (US)
Pages (from-to)249-268
Number of pages20
JournalTherapeutic Advances in Neurological Disorders
Issue number4
StatePublished - Jul 2013


  • MRI
  • demyelinating disease
  • multiple sclerosis
  • neuroimaging

ASJC Scopus subject areas

  • Pharmacology
  • Neurology
  • Clinical Neurology


Dive into the research topics of 'Neuroradiological evaluation of demyelinating disease'. Together they form a unique fingerprint.

Cite this